Boris Acevedo
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis, Celiac Disease Research and Management, Biochemical and Molecular Research, Biotechnology and Related Fields
Most-Cited Works
- → Antitumor Effect of a Novel Proapoptotic Peptide that Impairs the Phosphorylation by the Protein Kinase 2 (Casein Kinase 2)(2004)163 cited
- → Development and validation of a quantitative ELISA for the measurement of PSA concentration(2002)101 cited
- → CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo(2008)100 cited
- → An innovative sandwich ELISA system based on an antibody cocktail for gluten analysis(1998)86 cited
- → Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies(2009)80 cited
- → Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity(2009)71 cited
- → Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice(2007)64 cited
- → Heberprot-P: a novel product for treating advanced diabetic foot ulcer(2013)58 cited
- → One-step immunochromatographic assay for screening of coeliac disease(2002)50 cited
- → CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research(2011)43 cited